A class action lawsuit, issued on the behalf of users of the anti-diabetic drug Actos who have developed bladder cancer, was filed on July 31, 2012, in the Superior Court of Montreal.  The claimants, all residents of Quebec, are suing the manufacturers and distributors of Actos: the Japan-based Pharmaceutical Company, it affiliates, and Eli Lilly